Rchr
J-GLOBAL ID:202201008381399909   Update date: Nov. 12, 2024

Matsuse Dai

マツセ ダイ | Matsuse Dai
Affiliation and department:
Research theme for competitive and other funds  (15):
  • 2023 - 2026 ヘミチャネル阻害薬を用いたαシヌクレイン伝播阻止による多系統萎縮症の治療法開発
  • 2023 - 2025 Elucidation of glia inflammation mechanisms common to degeneration and demyelination by novel pathogenic microglia
  • 2022 - 2025 単一細胞RNA解析による多系統萎縮症増悪性ミクログリア亜群の同定と同細胞標的療法
  • 2020 - 2023 A novel model of multiple sclerosis and multiple system atrophy that are differentially manifested by the time of abnormal protein expression
  • 2020 - 2023 活性化グリア細胞制御による進行性多発性硬化症および多系統萎縮症の画期的治療法開発
Show all
Papers (41):
  • Hiroo Yamaguchi, Yuji Nishimura, Dai Matsuse, Hiroaki Sekiya, Katsuhisa Masaki, Tatsunori Tanaka, Toru Saiga, Masaya Harada, Yuu-Ichi Kira, Dennis W Dickson, et al. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates. Brain, behavior, and immunity. 2024. 121. 122-141
  • Emi Ueda, Mitsuru Watanabe, Daisuke Nakamura, Dai Matsuse, Eizo Tanaka, Kohta Fujiwara, Sawako Hashimoto, Shun Nakamura, Noriko Isobe, Koh-Hei Sonoda. Distinct retinal reflectance spectra from retinal hyperspectral imaging in Parkinson's disease. Journal of the neurological sciences. 2024. 461. 123061-123061
  • Yuji Nishimura, Katsuhisa Masaki, Dai Matsuse, Hiroo Yamaguchi, Tatsunori Tanaka, Eriko Matsuo, Shotaro Hayashida, Mitsuru Watanabe, Takuya Matsushita, Shoko Sadashima, et al. Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy. Brain pathology (Zurich, Switzerland). 2023. 33. 3. e13131
  • Jun Mitsui, Takashi Matsukawa, Yukari Uemura, Takuya Kawahara, Ayaka Chikada, Kristine Joyce L Porto, Hiroya Naruse, Masaki Tanaka, Hiroyuki Ishiura, Tatsushi Toda, et al. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial. EClinicalMedicine. 2023. 59. 101920-101920
  • Yu Hashimoto, Ryo Yamasaki, Senri Ko, Eriko Matsuo, Yuko Kobayakawa, Katsuhisa Masaki, Dai Matsuse, Noriko Isobe. Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation. International journal of molecular sciences. 2022. 23. 24
more...
MISC (3):
  • 松瀬 大. 進行性核上性麻痺. 2022
  • 松瀨 大, 吉良 潤一. 多発性硬化症・視神経脊髄炎. 2014
  • 松瀨 大, 吉良 潤一. 多発性硬化症. 2013
Lectures and oral presentations  (110):
  • 新規小脳型多系統萎縮症モデルのCSF-1R阻害剤治療
    (第15回パーキンソン病・運動障害疾患コングレス 2021)
  • パーキンソン病の病態と治療
    (大塚製薬株式会社社内講演 2021)
  • Early decrease of peripheral blood intermediate monocytes in multiple system atrophy cerebellar-type.
    (62nd Annual Meeting of the Japanese Society of Neurology 2021)
  • サフィナミド100mg投与意義~当院での使用経験も踏まえて~
    (PD診療WEBセミナー ~サフィナミド発売2周年を迎えて~ 2022)
  • 難病ネットワークの紹介
    (第2回福岡県難病診療連携拠点病院研修会 2022)
more...
Committee career (36):
  • 2022/04 - 2024/03 九州大学 自己点検・評価委員
  • 2019/11 - 2024/03 日本難病ネットワーク学会 評議員
  • 2022/02 - 2022/05 九州大学 病棟医長
  • 2022/02 - 2022/05 九州大学 感染対策委員
  • 2022/02 - 2022/05 九州大学 入院診療部門運営委員
Show all
Association Membership(s) (5):
日本再生医療学会 ,  日本神経免疫学会 ,  日本神経学会 ,  日本末梢神経学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page